Can a patch of the Eye's own tissue seal stubborn macular holes?

NCT ID NCT07760259

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial is testing whether a piece of the patient's own eye tissue, called Tenon's capsule, can help close large or recurrent macular holes—tears in the center of the retina that can blur or distort vision. During standard vitrectomy surgery, the tissue is harvested and placed over the hole, followed by a silicone oil fill to support healing. The study will follow 50 adults for six months to see if the hole closes and if vision improves, while also checking for any complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Autologous Tenon's capsule autograft (a piece of the patient's own eye tissue) implanted during vitrectomy surgery
What this could lead to
If successful, this could offer a new surgical option for difficult-to-treat macular holes, potentially improving closure rates and vision in patients who have few alternatives.
What could go wrong
This is a small, early-stage trial, and the procedure is complex. The graft may not integrate well, and there are risks of infection, bleeding, or other surgical complications. Results may not generalize to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MACULAR HOLE SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Benha University

    Banhā, Benha, 13111, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.